The Statin Market Gets Two New Players
Executive Summary
The market for statins, cholesterol-lowering drugs, just got more crowded as Bayer announced a co-promotion with SmithKline, which in turn followed the blockbuster deal for {lipitor} between Pfizer and Warner-Lambert. But some analysts already see a segmentation coming, with Bayer/SB going head-to-head against Bristol-Myer Squibb's {Pravachol}, while {Lipitor} competes against Merck's {Zocor}.
You may also be interested in...
Cosmetic Talc Stakeholders Should Be Watching US EPA Asbestos Developments In 2021
In December, a California federal court ordered the US Environmental Protection Agency to amend its TSCA Chemical Data Reporting rule to address asbestos information-gathering “loopholes,” including a current exemption for asbestos that occurs as an impurity in raw materials such as cosmetic talc.
QUOTED. 28 January 2021. Andrea Riposat.
L'Aquila, Italy-based Dante Laboratories company announced a £30m investment in global surveillance of new variants of the SARS-CoV-2 virus. CEO Andrea Riposat discussed the purchase.
Pharma Companies May Be Asked To Help Competitors Manufacture COVID-19 Vaccines
‘Everything is on the table,’ including invoking the Defense Production Act, White House COVID Coordinator Zients notes. Results of J&J’s Phase III vaccine trial expected ‘within next few days to a week.’
Need a specific report? 1000+ reports available
Buy Reports